Polypyrrole-contained electrospun conductive nanofibrous membranes for cardiac tissue engineering.
Cardiac tissue engineering (TE) is one of the most promising strategies to reconstruct infarct myocardium and the major challenge is to generate a bioactive substrate with suitable chemical, biological, and conductive properties, thus mimicking the extracellular matrix (ECM) both structurally and functionally. In this study, polypyrrole/poly(ε-caprolactone)/gelatin nanofibrous scaffolds were electrospun by incorporating different concentrations of polypyrrole (PPy) to PCL/gelatin (PG) solution. Morphological, chemical, mechanical, and biodegradation properties of the electrospun nanofibers were evaluated. Our data indicated that by increasing the concentration of PPy (0-30%) in the composite, the average fiber diameters reduced from 239 ± 37 nm to 191 ± 45 nm, and the tensile modulus increased from 7.9 ± 1.6 MPa to 50.3 ± 3.3 MPa. Conductive nanofibers containing 15% PPy (PPG15) exhibited the most balanced properties of conductivity, mechanical properties, and biodegradability, matching the requirements for regeneration of cardiac tissue. The cell proliferation assay, SEM, and immunostaining analysis showed that the PPG15 scaffold promote cell attachment, proliferation, interaction, and expression of cardiac-specific proteins better than PPG30. Electrospun PPG15 conductive nanofibrous scaffold could be desirable and promising substrates suitable for the regeneration of infarct myocardium and cardiac defects.
NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore, Singapore.
Dan
D
Kai
Molamma P
MP
Prabhakaran
Guorui
G
Jin
Seeram
S
Ramakrishna
D000818:Animals; D049109:Cell Proliferation / Q000187:drug effects; D048430:Cell Shape / Q000187:drug effects; D004553:Electric Conductivity; D005455:Fluorescent Antibody Technique; D005780:Gelatin / Q000494:pharmacology; D006321:Heart / Q000187:drug effects* / Q000502:physiology*; D008422:Materials Testing; D008567:Membranes, Artificial; D009206:Myocardium / Q000166:cytology / Q000378:metabolism; D032383:Myocytes, Cardiac / Q000166:cytology / Q000187:drug effects; D057139:Nanofibers / Q000737:chemistry* / Q000648:ultrastructure; D011091:Polyesters / Q000494:pharmacology; D011108:Polymers / Q000494:pharmacology*; D011758:Pyrroles / Q000494:pharmacology*; D011817:Rabbits; D017550:Spectroscopy, Fourier Transform Infrared; D023822:Tissue Engineering / Q000379:methods*
D008567:Membranes, Artificial; D011091:Polyesters; D011108:Polymers; D011758:Pyrroles; C016240:polycaprolactone; C067635:polypyrrole; D005780:Gelatin